In terms of technology, the vaccine is a poly-antigenic, anti-cancer which is derived from the tissue cells infected with human-aliens cancer. Due to its being 100% alienated from human cells, the vaccine is able to make the strongest possible effect on human immune system. Surface of components of the vaccine cells contains the main cancer antigens, which of carcinomas and xenogenic antigens, which form a powerful target towards the human immune system and due to these development of a vital anti-cancer reaction of human body is evoked. Not only the general chains of immunity but the immune memory of a human body is triggered and synthesis of endogenous biologically active cytokines is induced.
Clinical indications for the application of poly-antigenic anti-cancer vaccine.
Melanoma,breast, prostate, renal, colorectal, ovarian cancer, brain tumor and all types of carcinoma cancer types. All active patients in remission are good candidate for this immunotherapy drug.
Stage of cancer development.
Immunotherapy is always giving the best results in the early stages of disease.
Xenovaccine course is not less than 10 vials. Recommended application scheme is: 4 subcutaneous shots 4 times a month, then 2 subcutaneous shots 2 times a month and 1 shot each month till 10 vaccinations have been performed.
Please like,comment and share I'll do the samehttps://www.sciencedirect.com/science/article/pii/S0753332206003490
Content created and supplied by: Sherezadé (via Opera News )